Randomized controlled phase II study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer.

被引：0
|
作者：
Nakamura, Seiichi
Tatebe, Shigeru
Shimizu, Tetsu
Yamane, Nariyuki
Nishidoi, Hideaki
Kurisu, Yasuro
Kanayama, Hirotomo
Ogawa, Haruaki
Tsujitani, Shunichi
Ikeguchi, Masahide
机构：
[1] Tottori Prefectural Cent Hosp, Tottori, Japan
[2] Tottori Univ, Yonago, Tottori, Japan
[3] Yonago Med Ctr, Yonago, Tottori, Japan
[4] Tottori Red Cross Hosp, Tottori, Japan
[5] Hamada Med Ctr, Hamada, Japan
[6] Matsue City Hosp, Matsue, Shimane, Japan
[7] Yasugi Municipal Hosp, Yasugi, Japan
[8] Kyushu Univ, Dept Surg & Sci, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Complete remission of peritoneal dissemination of colon cancer by alternate-day S-1 and oxaliplatin plus bevacizumab treatment and maintenance chemotherapy comprising alternate-day S-1 plus bevacizumab: A case report
    Nitori, Nobuhiro
    Kato, Ayu
    Deguchi, Tomoaki
    Nakadai, Jumpei
    Tada, Ayako
    Takahashi, Makoto
    Umeda, Rumiko
    Miyata, Naoteru
    Kataoka, Mikinori
    Kadomura, Tomohisa
    Higuchi, Hajime
    Ebinuma, Hirotoshi
    Kato, Atsushi
    Hatori, Takashi
    Ikeda, Yoshifumi
    Miyazaki, Masaru
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (02) : 270 - 274
  • [22] A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy for colorectal cancer: The AIRS study
    Honda, M.
    Matsuda, C.
    Tanaka, C.
    Kondo, K.
    Takahashi, T.
    Kosugi, C.
    Tokunaga, Y.
    Takemoto, H.
    Kim, H. M.
    Sakamoto, J.
    Oba, K.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2018, 29 : 161 - 161
  • [23] S-1 adjuvant chemotherapy for advanced gastric cancer
    David Kelsen
    Nature Clinical Practice Oncology, 2008, 5 : 370 - 371
  • [24] S-1 adjuvant chemotherapy for advanced gastric cancer
    Kelsen, David
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 370 - 371
  • [25] Phase II study of S-1 and docetaxel combination in advanced or recurrent gastric cancer.
    Yoshida, K
    Toge, T
    Ninomiya, M
    Takakura, N
    Hirabayashi, N
    Takiyama, W
    Sato, Y
    Terashima, M
    Goto, M
    Sakamoto, J
    Nishiyama, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 320S - 320S
  • [26] A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
    Matsuda, Chu
    Honda, Michitaka
    Tanaka, Chihiro
    Kondo, Ken
    Takahashi, Takao
    Kosugi, Chihiro
    Tokunaga, Yukihiko
    Takemoto, Hiroyoshi
    Kim, Ho Min
    Sakamoto, Junichi
    Oba, Koji
    Mishima, Hideyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1035 - 1041
  • [27] A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study
    Chu Matsuda
    Michitaka Honda
    Chihiro Tanaka
    Ken Kondo
    Takao Takahashi
    Chihiro Kosugi
    Yukihiko Tokunaga
    Hiroyoshi Takemoto
    Ho Min Kim
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 1035 - 1041
  • [28] Chemotherapy for Gastric Cancer that Recurs After Adjuvant Chemotherapy with S-1
    Shitara, Kohei
    Muro, Kei
    Ura, Takashi
    Takahari, Daisuke
    Yokota, Tomoya
    Sawaki, Akira
    Kawai, Hiroki
    Ito, Seiji
    Yamamura, Yoshitaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (11) : 786 - 789
  • [29] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    Takahari, D.
    Hamaguchi, T.
    Yoshimura, K.
    Katai, H.
    Ito, S.
    Fuse, N.
    Kinoshita, T.
    Yasui, H.
    Terashima, M.
    Goto, M.
    Tanigawa, N.
    Shirao, K.
    Sano, T.
    Sasako, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1423 - 1428
  • [30] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    D. Takahari
    T. Hamaguchi
    K. Yoshimura
    H. Katai
    S. Ito
    N. Fuse
    T. Kinoshita
    H. Yasui
    M. Terashima
    M. Goto
    N. Tanigawa
    K. Shirao
    T. Sano
    M. Sasako
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1423 - 1428
12345